N-Ethyl-2C-B

N-Ethyl-2C-B
Legal status
Legal status	UK: In General Unscheduled;
Identifiers
	IUPAC name 2-(4-bromo-2,5-dimethoxyphenyl)-N-ethylethanamine;
CAS Number	155639-24-0 ;
PubChem CID	10379339;
ChemSpider	8554782;
UNII	JC6CK9H75Z;
ChEMBL	ChEMBL57147;
CompTox Dashboard (EPA)	DTXSID601336903 ;
Chemical and physical data
Formula	C12H18BrNO2
Molar mass	288.185 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC(CCNCC)=C(OC)C=C1Br;
	InChI InChI=1S/C12H18BrNO2/c1-4-14-6-5-9-7-12(16-3)10(13)8-11(9)15-2/h7-8,14H,4-6H2,1-3H3; Key:FTXAZQUDSNEXMB-UHFFFAOYSA-N;

N-Ethyl-2C-B is a recreational designer drug with psychedelic effects.^[1] It was first synthesised in the 1990s,^[2] and was first identified as a new psychoactive substance in Finland in 2007.^[3] It is specifically listed as an illegal drug in Finland,^[4] and controlled under analogue provisions in a number of other jurisdictions.

References

^ Schifano F, Orsolini L, Papanti D, Corkery J (2017). "NPS: Medical Consequences Associated with Their Intake". Neuropharmacology of New Psychoactive Substances (NPS). Current Topics in Behavioral Neurosciences. Vol. 32. pp. 351–380. doi:10.1007/7854_2016_15. ISBN 978-3-319-52442-9. PMID 27272067.
^ Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K (June 1994). "Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines". Journal of Medicinal Chemistry. 37 (13): 1929–35. doi:10.1021/jm00039a004. PMID 8027974.
^ "2007 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) & Europol.
^ "Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista" [Government Decree on Psychoactive Substances Banned from the Consumer Market]. Finlex Data Bank (in Finnish).

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[pmid27272067-1] Schifano F, Orsolini L, Papanti D, Corkery J (2017). "NPS: Medical Consequences Associated with Their Intake". Neuropharmacology of New Psychoactive Substances (NPS). Current Topics in Behavioral Neurosciences. Vol. 32. pp. 351–380. doi:10.1007/7854_2016_15. ISBN 978-3-319-52442-9. PMID 27272067.

[pmid8027974-2] Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K (June 1994). "Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines". Journal of Medicinal Chemistry. 37 (13): 1929–35. doi:10.1021/jm00039a004. PMID 8027974.

[3] "2007 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) & Europol.

[4] "Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista" [Government Decree on Psychoactive Substances Banned from the Consumer Market]. Finlex Data Bank (in Finnish).

[1]

[2]

[3]

[4]

N-Ethyl-2C-B

See also

References

zproxy.org

Legal status

Legal status	UK: In General Unscheduled
Identifiers
IUPAC name 2-(4-bromo-2,5-dimethoxyphenyl)-N-ethylethanamine
CAS Number	155639-24-0^Y
PubChem CID	10379339
ChemSpider	8554782
UNII	JC6CK9H75Z
ChEMBL	ChEMBL57147
CompTox Dashboard (EPA)	DTXSID601336903
Chemical and physical data
Formula	C₁₂H₁₈BrNO₂
Molar mass	288.185 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES COC1=CC(CCNCC)=C(OC)C=C1Br
InChI InChI=1S/C12H18BrNO2/c1-4-14-6-5-9-7-12(16-3)10(13)8-11(9)15-2/h7-8,14H,4-6H2,1-3H3 Key:FTXAZQUDSNEXMB-UHFFFAOYSA-N